page 1 iop genomics workshop patents and patenting biotech inventions annemieke breukink, ph.d....
TRANSCRIPT
Page 1
IOP Genomics WorkshopIOP Genomics WorkshopPatents and Patenting Biotech InventionsPatents and Patenting Biotech Inventions
Annemieke Breukink, Ph.D.
September 8th, 2009
Page 2
Outline presentationOutline presentation
I. IP Rights and patent law
II. Patent procedure & costs
III. Patent strategy
IV. Patents and Biotechnology
Page 3
Patents
Trademarks
Designs
Copyright
Database right
Trading names Ahold
Intellectual property rights:Intellectual property rights:
Other rights:no registration required
Industrial rights:registration required
Page 4
What is a patent ?What is a patent ?
An exclusive right, granted by the state, to exclude others from making, selling, etc. your invention during a specific period in the jurisdiction of the state.
Page 6
The patent The patent system:system: Patent
Monopoly to
recover investments
Disclosure of
technical progress
R&D
Patent
PROTECTION INFORMATION
Page 9
• First to file principlecompany vs employee patentapplicant vs inventor
• Inventor: right to be mentionedentitled to compensation (cao)
Who obtains patent right ?Who obtains patent right ? (art. 12 Dutch Patent Act 1995)
Page 10
Legal requirementsLegal requirements
• Novel• Involve an inventive step• Industrially applicable• Technical invention • Clear and complete disclosure
Page 11
Patent infringement ?Patent infringement ?
• Commercial exploitation
• Research (scientific, fundamental) • Prior use
YES:
NO:
• Contract research• Clinical trialsMAYBE:
Page 14
Patent system in the NetherlandsPatent system in the Netherlands
• Dutch Patent Act (ROW 1995)
• European Patent Convention (1973); EPC 2000
• Patent Cooperation Treaty (PCT; 1970)
Page 15
Patent procedure:Patent procedure:establishment of patent right
0 12 18
publication
Time (months)priority year
examinationfiling search
20Y
Page 16
Example of a patent familyExample of a patent family
2,5 y
WO 01/10739PCT procedure
USA
Japan
Europe (EP)NetherlandsGermanyGreat Britain
1,5 ypubl.
France……
1 yNetherlandsapplication
JP 2001/072151
NL 1018659
US 6569387
EP 1076014
EP Grant
20 y
Page 17
Patent procedure: total costsPatent procedure: total costs
• National € 5.000, result: Dutch patent
• European (EPO)€ 30.000, result: bundle of national patents
• International “PCT” (WIPO)€ 150.000, result: bundle of patent applications
Page 19
• Cost of investment
• (R&D, clinical trials)
• New technology
• Highly competitive field
• Financial risks
Importance of patents Importance of patents in the biotech/pharmacy field:in the biotech/pharmacy field:
Page 20
Patent protection:Patent protection: company point of viewcompany point of view
• Protect product or process (invention)patent = monopoly = market investment protection
• Negotiation toolstop or collaborate competitors sell or buy technical know-how
• Venture capital attract investorsimage
Page 21
Patent protection:Patent protection:university point of viewuniversity point of view
• Why apply for a patent?publish or perish
negotiation position
• Finance, who pays?university budgettechnology transfer?
• Who benefits?
Page 22
• (Increase) collaboration with industry
• Generate new source of funding
• Potential breakthrough technology ?
• Patent does not exclude publication
Patent protection:Patent protection:university considerationsuniversity considerations
Page 25
Execution
Desk research
Research proposal
Publication
Search literature in scientific publications
Patent literature as source of inspiration
Write research proposal
Patent literature assource of information
Obtain funds forresearch
Plan costs for patentapplication
Make records of results / Invention based on research
Registration of invention(s)
Financing
Approach:Approach: Combining Combining Patents and Patents and ResearchResearch
Page 26
• Examine the field of your invention - Use patent literature
- Know the key companies
• Apply for a patent: obtain a priority date• Or sell your patent idea.
- Inventor is inventor
• Attract key companies attention- Sell / License / Project within 30 month period
• Proceed with your research
StrategyStrategy: Plan for Exploration: Plan for Exploration
Page 28
Patent statistics:Patent statistics:
• Each year >140.000 European patent applications
• .. 5 % concerns biotechnology
Page 30
PPatentatent requirements requirements
• Absolute novelty
• Inventive step
• Industrial application
Invention:
Page 34
“The selective occupation of a receptor cannot be considered in itself as a therapeutic application; the discovery that a substance selectively binds a receptor, even if representing an important piece of scientific knowledge, still needs to find a practical application in the form of a defined, real treatment of any pathological condition in order to make a technical contribution to the art and to be considered as an invention eligible for patent protection”
Page 36
Unpatentable subject matter:Unpatentable subject matter:
• Discoveries• Scientific theories, mathematical methods• Computer programs• Aesthetic creations• Business methods• Treatment of human / animal body• Inventions contrary to “ordre public”
Page 38
Unpatentable (biotech) inventionsUnpatentable (biotech) inventionsregulated by:regulated by:
Dutch Patents Act 1995
European patent convention (EPC)
Directive on Biotechnological inventions 98/44/EC
Page 39
Unpatentable (biotech) inventions:Unpatentable (biotech) inventions:
• Plant or animal variety
• (parts of) human body which are not “isolated”
• DNA/protein sequence without description of function
• Method for cloning humans
• Method for altering genetic identity humans
• Method for altering genetic identity animals : suffering?
• Industrial or commercial use of embryo’s
Page 40
Patentable (biotech) inventions:Patentable (biotech) inventions:
• Methods (e.g. DNA-array, cDNA library screening)
• Isolated (parts of) human body (proteins, enzymes)
• Isolated (partial) DNA sequence with function
• Genetically modified organism
• …….
Page 41
• A method to…
• Use of X for…
• A product
Patenting (biotech) inventionsPatenting (biotech) inventions
Allowable subject matter